OnKure Therapeutics, Inc. (OKUR) NASDAQ
4.05
+0.145(+3.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.05
+0.145(+3.72%)
Currency In USD
| Market Cap | 39.2M |
| Enterprise Value | -19.3M |
| P/E Ratio | -0.92 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.96 |
| Return On Equity | -0.82 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -830,000 |
| EBITDA | -62.12M |
| Net Income | -59.52M |
| Diluted EPS | -4.4 |
| Total Cash | 59.05M |
| Total Cash/Share | 4.37 |
| Total Debt | 549,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.28 |
| Book Value Per Share | 4.16 |
| 52-Week Change | -16.08 |
| 52-Week High | 5.28 |
| 52-Week Low | 1.7 |
| Moving Average 50 Days | 2.87 |
| Moving Average 200 Days | 2.76 |
| Average Volume | 119,559 |
| Shares Outstanding | 13.55M |
| % Held by Institutions | 81.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 07, 2024 |